Shopping Cart 0
Cart Subtotal
USD 0

Organ-On-Chip Global Market Opportunities And Strategies To 2021 Including: Lung-On-Chip, Heart-On-Chip, Liver-On-Chip, Intestine-On-Chip, Kidney-On-Chip, Skin-On-Chip, Blood-Brain-Barrier-On-Chip And Human-On-Chip Covering: CN Bio Innovations, Emulate, TissUse, Mimetas, Hurel, Nortis, InSphero, Tara Biosystems, AxoSim Technologies, Organovo, Ascendence And HemoShear

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 4000

Access to Printed Report; No Soft Copy
Print Option: N/A
Copy Option: N/A
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
USD 4000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 6000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

CD-Rom
USD 4000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 8000
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Scientific advances in cell biology, microfabrication and microfluidics have led to the development of Organ-on-Chips (OOCs). OOCs are microfluidic 3D cell culture devices that closely mimic the key physiological functions of body organs. These chips are not designed to biomimic an entire organ, but simulate the physiology of a single functional unit of an organ system.

 

These microchips are one of the most exciting areas of scientific research as they have the distinguishing characteristic of emulating the human micro environment in vitro. This unique feature of OOCs is made possible by integrating biology with advanced engineering technologies.

 

OOC technology is still at an initial stage of research, development and commercialization. The players in the market are primarily university spinoffs involved in the commercialization of OOC prototypes developed in the universities. The key players include Emulate, CN-Bio Innovations, InSphero, Mimetas, TissUse, H�rel and Nortis. Currently OOCs are marketed primarily through sales agreements with end-users that involve collaboration of both parties in tailoring the OOCs to meet the end-user's requirements.

 

The global market for OOCs was valued at USD 20 million in 2016. It is expected to grow at a compound annual growth rate (CAGR) of 70% to reach USD 284 million by 2021. The small size of the market is mainly due to the fact that OOCs have not yet been fully commercialized. They are still in the research and development phase and are primarily being used by a limited number of end-users. The OOC market is expected to rise at this high CAGR due to an increase in the number of collaborative sales agreements between the pharmaceutical companies and university spin-offs and the entry of new advanced models of OOCs into the market. The anticipated launch of advanced organ-specific models and human-on-chip models is expected to further increase the growth rate of this market in future.

 

Further improvements in the design and manufacture of OOCs will probably replace animal models as subjects in preclinical drug evaluations in future. Overall, they have the potential to break an impasse in in-vitro drug discovery and development.

READ MORE

Table Of Content

Scope

1 Executive Summary

2 Preface

3 Global Organ-On-Chip Market-Introduction

4 Organ-On-Chip Market Characteristics

4.1.1 Organs-On-Chips Origin And Significance

4.1.2 Organ-On-Chip Features

4.2 Organ-On-Chip Market-Product Analysis

4.2.1 Technical Description

4.2.2 Typical Organ-On-Chip Structure

4.2.3 Product Design Materials

4.2.4 Product Design Methodologies

5 Overview Of Organ-Specific Models

5.1 Lung-On-Chip

5.2 Heart-On-Chip

5.3 Liver-On-Chip

5.4 Intestine-On-Chip

5.5 Kidney-On-Chip

5.6 Skin-On-Chip

5.7 Blood-Brain-Barrier-On-Chip

5.8 Human-On-Chip

6 Organ-On-Chip Applications

7 Organ-On-Chip Commercialization

8 Organ-On-Chip Market Penetration

9 Price Information

10 Organ-On-Chip Market Trends and Models

10.1 Global Organ-On-Chip Market-Business Model

10.2 Five Forces Analysis

10.3 Market Trends

10.3.1 Developments In The Testing Of Human Organs-On-Chips

10.3.2 Organ-On-Chip Technology In Space

10.3.3 Automated Monitoring Of Organs-On-Chips

10.3.4 3D Printing Of Organs-On Chips

10.3.5 Manufacturers Tying Up With End-Users To Design Tailor-made Products

10.3.6 Investment In Integration Of Individual Organs-on-Chips Into Humans-on-Chips

10.3.7 Strong Focus On Development of Custom Organs-On-Chips

10.3.8 Manufacturers Work On Disease Models To Expedite Drug Testing

11 Global Organ-On-Chip Market-Market Size Analysis

11.1 Market Sizing Methodology

11.2 Global Market For Organs-on-Chips

11.2.1 Global Market For Organs-On-Chips (Historic 2013-2017)

11.2.2 Global Market For Organs-On-Chips (Forecast 2017-2021)

11.3 Global Organ-On-Chip Market Segmentation By Organ Type

11.4 Global Organ-On-Chip Market Segmentation By End-Users

11.4.1 Pharmaceuticals

11.4.2 Research Organizations

11.4.3 Consumer Goods and Cosmetics

11.4.4 Food and Beverages

11.4.5 Others

11.5 Global Organ-On-Chip Market Segmentation By Geography

11.5.1 North America

11.5.2 Europe

11.5.3 Asia

11.5.4 Rest Of World (ROW)

12 Global Organ-On-Chip Market-Drivers And Restraints

12.1 Drivers

12.1.1 Improved Drug Screening With Organs-On-Chips Will Drive Demand

12.1.2 Drug Testing Cost Savings to Drive Demand For OOCs

12.1.3 Government Funding Drives The Market For Organs-On-Chips

12.1.4 Ethical Concerns With Respect To Animal Models Will Drive The Organ-On-Chip Market

12.2 Restraints

12.2.1 Complex Manufacturing Techniques Are A Restraint On Organ-On-Chip Market Growth

12.2.2 Requirement For Specialized Equipment Will Be A Challenge For The Organ-On-Chip Market

12.2.3 Regulatory Hurdles For Drug Approvals

13 Global Organ-On-Chip Market-Funding Landscape

13.1.1 Funding Landscape-North America

13.1.2 Funding Landscape-Europe

13.1.3 Funding Landscape-Asia

13.1.4 Funding Landscape-ROW

14 Global Organ-On-Chip Market-Competitive Landscape

14.1 Key Players In The OOC Market

14.2 CN Bio Innovations

14.3 Emulate

14.4 TissUse

14.5 Mimetas

14.6 H�rel

14.7 Nortis

14.8 Insphero

14.9 Tara Biosystems

14.10 AxoSim Technologies LLC

14.11 Organovo

14.12 Ascendance

14.13 HemoShear

15 Global Organ-On-Chip Market-Conclusions and Strategies

15.1 Conclusions

15.2 Strategies

16 Appendix

16.1 Interview Summaries

16.1.1 Interview Number 1

16.1.2 Interview Number 2

16.1.3 Interview Number 3

16.1.4 Interview Number 4

16.1.5 Interview Number 5

16.1.6 Interview Number 6

16.1.7 Interview Number 7

16.2 Abbreviations

16.3 Research Methodology

16.4 Currencies

16.5 Research Inquiries

16.6 The Business Research Company


List Of Figure

Figure 1: Global Organ-On-Chip Market, Typical Organ-On-Chip Structure

Figure 2: Global Organ-On-Chip Market, Lung-On-Chip Model

Figure 3: Global Organ-On-Chip Market, Heart-On-Chip Model

Figure 4: Global Organ-On-Chip Market, Liver-On-Chip Model

Figure 5: Global Organ-On-Chip Market, Intestine-On-Chip Model

Figure 6: Global Organ-On-Chip Market, Kidney-On-Chip Model

Figure 7: Global Organ-On-Chip Market, Skin-On-Chip Model

Figure 8: Global Organ-On-Chip Market, Blood-Brain-Barrier-On-Chip Model

Figure 9: Global Organ-On-Chip Market, Human-On-Chip Model

Figure 10: Global Organ-On-Chip Market, Typical Business Model Of OOC Companies

Figure 11: Global Organ-On-Chip Market, Five Forces Analysis

Figure 12: Global Organ-On-Chip Historic Market Size, 2013-2017, Value (USD million)

Figure 13: Global Organ-On-Chip Forecast Market Size, 2017-2021, Value (USD million)

Figure 14: Global Organ-On-Chip Market, Segmentation By Organ Type, 2017, (% share)

Figure 15: Global Organ-On-Chip Market Segmentation By End-Users, 2017, Value (USD million)

Figure 16: North America Organ-On-Chip Market, Historic Market Size, 2013-2017, Value (USD million)

Figure 17: North America Organ-On-Chip Market, Forecast Market Size, 2017-2021, Value (USD million)

Figure 18: Europe Organ-On-Chip Market, Historic Market Size, 2013-2017, Value (USD million)

Figure 19: Europe Organ-On-Chip Market, Forecast Market Size, 2017-2021, Value (USD million)

Figure 20: Asia Organ-On-Chip Market, Historic Market Size, 2013-2017, Value (USD million)

Figure 21: Asia Organ-On-Chip Market, Forecast Market Size, 2017-2021, Value (USD million)

Figure 22: ROW Organ-On-Chip Market, Historic Market Size, 2013-2017, Value (USD million)

Figure 23: ROW Organ-On-Chip Market, Forecast Market Size, 2017-2021, Value (USD million)

Figure 24: Global Organ-On-Chip Market, Predictability Scale Of Techniques In Drug Screening And Evaluation

Figure 25: Global Organ-On-Chip Market, Number Of New Drug Approvals By FDA And EMA, 2013-2016

Figure 26: Global Organ-On-Chip Market Funding Landscape Split By Regions, 2015-2017, Value, (USD million)

Figure 27: Global Organ-On-Chip Market Key Competitors Revenues, 2017 (USD million)


List Of Table

Table 1: Global Organ-On-Chip Market, List Of Universities And Their Spin-offs

Table 2: Global Organ-On-Chip Market, Historic Market Size, 2013-2017, Value (USD million)

Table 3: Global Organ-On-Chip Market, Forecast Market Size, 2017-2021, Value (USD million)

Table 4: Global Organ-On-Chip Market,Segmentation By Organ Type, 2017, (% share)

Table 5: Global Organ-On-Chip Market, Segmentation By End-Users, 2017, Value (USD million)

Table 6: North America Organ-On-Chip Market, Historic Market Size, 2013-2017, Value (USD million)

Table 7: North America Organ-On-Chip Market, Forecast Market Size, 2017-2021, Value (USD million)

Table 8: Europe Organ-On-Chip Market, Historic Market Size, 2013-2017, Value (USD million)

Table 9: Europe Organ-On-Chip Market, Forecast Market Size, 2017-2021, Value (USD million)

Table 10: Asia Organ-On-Chip Market, Historic Market Size, 2013-2017, Value (USD million)

Table 11: Asia Organ-On-Chip Market, Forecast Market Size, 2017-2021, Value (USD million)

Table 12: ROW Organ-On-Chip Market, Historic Market Size, 2013-2017, Value (USD million)

Table 13: ROW Organ-On-Chip Market, Forecast Market Size, 2017-2021, Value (USD million)

Table 14: Global Organ-On-Chip Market, Top Pharmaceutical Companies-R&D Expenditures, 2015 and 2016, (USD billion)

Table 15: Global Organ-On-Chip Market, Number Of New Drug Approvals By FDA And EMA, 2013-2016

Table 16: Global Organ-On-Chip Market, Institutions Funded By NIH, 2017

Table 17: Global Organ-On-Chip Market, Institutions Funded By NCATS For Tissue Chip Testing Centers, 2016

Table 18: Global Organ-On-Chip Market, Institutions Funded By NCATS, 2017

Table 19: Global Organ-On-Chip Market, CN Bio Collaborations With Pharmaceutical Companies

Table 20: Global Organ-On-Chip Market, CN Bio Collaborations With Academic Institutions

Table 21: Global Organ-On-Chip Market, H�REL Products and its Description

Table 22: Global Organ-On-Chip Market, InSphero Products and its Description

Table 23: Global Organ-On-Chip Market, InSphero Collaborations With Academic Universities And Industries

Licence Rights

  • Single User License (for access by one person)
  • Site License (for access of one office location of a company)
  • Corporate License (allow access by all staff of the company)

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Lung-on-chip, Heart-on-chip, Liver-on-chip, Intestine-on-chip, Kidney-on-chip and Human-on-chip


Companies

North America: Emulate Inc., H�REL Corporation (H�REL), Nortis, Tara Biosystems, AxoSim Techologies LLC, Organovo, ASCENDANCE BIOTECHNOLOGY - HEPREGEN,

Europe: CN Bio Innovations, TissUse GmbH, Mimetas, InSphero, HemoShear, Roche Holding AG, Elvesys, Cherry Biotech, 4Dcell

Asia: Kyoto University

Scientific advances in cell biology, microfabrication and microfluidics have led to the development of Organ-on-Chips (OOCs). OOCs are microfluidic 3D cell culture devices that closely mimic the key physiological functions of body organs. These chips are not designed to biomimic an entire organ, but simulate the physiology of a single functional unit of an organ system.

 

These microchips are one of the most exciting areas of scientific research as they have the distinguishing characteristic of emulating the human micro environment in vitro. This unique feature of OOCs is made possible by integrating biology with advanced engineering technologies.

 

OOC technology is still at an initial stage of research, development and commercialization. The players in the market are primarily university spinoffs involved in the commercialization of OOC prototypes developed in the universities. The key players include Emulate, CN-Bio Innovations, InSphero, Mimetas, TissUse, H�rel and Nortis. Currently OOCs are marketed primarily through sales agreements with end-users that involve collaboration of both parties in tailoring the OOCs to meet the end-user's requirements.

 

The global market for OOCs was valued at USD 20 million in 2016. It is expected to grow at a compound annual growth rate (CAGR) of 70% to reach USD 284 million by 2021. The small size of the market is mainly due to the fact that OOCs have not yet been fully commercialized. They are still in the research and development phase and are primarily being used by a limited number of end-users. The OOC market is expected to rise at this high CAGR due to an increase in the number of collaborative sales agreements between the pharmaceutical companies and university spin-offs and the entry of new advanced models of OOCs into the market. The anticipated launch of advanced organ-specific models and human-on-chip models is expected to further increase the growth rate of this market in future.

 

Further improvements in the design and manufacture of OOCs will probably replace animal models as subjects in preclinical drug evaluations in future. Overall, they have the potential to break an impasse in in-vitro drug discovery and development.

READ MORE

Scope

1 Executive Summary

2 Preface

3 Global Organ-On-Chip Market-Introduction

4 Organ-On-Chip Market Characteristics

4.1.1 Organs-On-Chips Origin And Significance

4.1.2 Organ-On-Chip Features

4.2 Organ-On-Chip Market-Product Analysis

4.2.1 Technical Description

4.2.2 Typical Organ-On-Chip Structure

4.2.3 Product Design Materials

4.2.4 Product Design Methodologies

5 Overview Of Organ-Specific Models

5.1 Lung-On-Chip

5.2 Heart-On-Chip

5.3 Liver-On-Chip

5.4 Intestine-On-Chip

5.5 Kidney-On-Chip

5.6 Skin-On-Chip

5.7 Blood-Brain-Barrier-On-Chip

5.8 Human-On-Chip

6 Organ-On-Chip Applications

7 Organ-On-Chip Commercialization

8 Organ-On-Chip Market Penetration

9 Price Information

10 Organ-On-Chip Market Trends and Models

10.1 Global Organ-On-Chip Market-Business Model

10.2 Five Forces Analysis

10.3 Market Trends

10.3.1 Developments In The Testing Of Human Organs-On-Chips

10.3.2 Organ-On-Chip Technology In Space

10.3.3 Automated Monitoring Of Organs-On-Chips

10.3.4 3D Printing Of Organs-On Chips

10.3.5 Manufacturers Tying Up With End-Users To Design Tailor-made Products

10.3.6 Investment In Integration Of Individual Organs-on-Chips Into Humans-on-Chips

10.3.7 Strong Focus On Development of Custom Organs-On-Chips

10.3.8 Manufacturers Work On Disease Models To Expedite Drug Testing

11 Global Organ-On-Chip Market-Market Size Analysis

11.1 Market Sizing Methodology

11.2 Global Market For Organs-on-Chips

11.2.1 Global Market For Organs-On-Chips (Historic 2013-2017)

11.2.2 Global Market For Organs-On-Chips (Forecast 2017-2021)

11.3 Global Organ-On-Chip Market Segmentation By Organ Type

11.4 Global Organ-On-Chip Market Segmentation By End-Users

11.4.1 Pharmaceuticals

11.4.2 Research Organizations

11.4.3 Consumer Goods and Cosmetics

11.4.4 Food and Beverages

11.4.5 Others

11.5 Global Organ-On-Chip Market Segmentation By Geography

11.5.1 North America

11.5.2 Europe

11.5.3 Asia

11.5.4 Rest Of World (ROW)

12 Global Organ-On-Chip Market-Drivers And Restraints

12.1 Drivers

12.1.1 Improved Drug Screening With Organs-On-Chips Will Drive Demand

12.1.2 Drug Testing Cost Savings to Drive Demand For OOCs

12.1.3 Government Funding Drives The Market For Organs-On-Chips

12.1.4 Ethical Concerns With Respect To Animal Models Will Drive The Organ-On-Chip Market

12.2 Restraints

12.2.1 Complex Manufacturing Techniques Are A Restraint On Organ-On-Chip Market Growth

12.2.2 Requirement For Specialized Equipment Will Be A Challenge For The Organ-On-Chip Market

12.2.3 Regulatory Hurdles For Drug Approvals

13 Global Organ-On-Chip Market-Funding Landscape

13.1.1 Funding Landscape-North America

13.1.2 Funding Landscape-Europe

13.1.3 Funding Landscape-Asia

13.1.4 Funding Landscape-ROW

14 Global Organ-On-Chip Market-Competitive Landscape

14.1 Key Players In The OOC Market

14.2 CN Bio Innovations

14.3 Emulate

14.4 TissUse

14.5 Mimetas

14.6 H�rel

14.7 Nortis

14.8 Insphero

14.9 Tara Biosystems

14.10 AxoSim Technologies LLC

14.11 Organovo

14.12 Ascendance

14.13 HemoShear

15 Global Organ-On-Chip Market-Conclusions and Strategies

15.1 Conclusions

15.2 Strategies

16 Appendix

16.1 Interview Summaries

16.1.1 Interview Number 1

16.1.2 Interview Number 2

16.1.3 Interview Number 3

16.1.4 Interview Number 4

16.1.5 Interview Number 5

16.1.6 Interview Number 6

16.1.7 Interview Number 7

16.2 Abbreviations

16.3 Research Methodology

16.4 Currencies

16.5 Research Inquiries

16.6 The Business Research Company


List Of Figure

Figure 1: Global Organ-On-Chip Market, Typical Organ-On-Chip Structure

Figure 2: Global Organ-On-Chip Market, Lung-On-Chip Model

Figure 3: Global Organ-On-Chip Market, Heart-On-Chip Model

Figure 4: Global Organ-On-Chip Market, Liver-On-Chip Model

Figure 5: Global Organ-On-Chip Market, Intestine-On-Chip Model

Figure 6: Global Organ-On-Chip Market, Kidney-On-Chip Model

Figure 7: Global Organ-On-Chip Market, Skin-On-Chip Model

Figure 8: Global Organ-On-Chip Market, Blood-Brain-Barrier-On-Chip Model

Figure 9: Global Organ-On-Chip Market, Human-On-Chip Model

Figure 10: Global Organ-On-Chip Market, Typical Business Model Of OOC Companies

Figure 11: Global Organ-On-Chip Market, Five Forces Analysis

Figure 12: Global Organ-On-Chip Historic Market Size, 2013-2017, Value (USD million)

Figure 13: Global Organ-On-Chip Forecast Market Size, 2017-2021, Value (USD million)

Figure 14: Global Organ-On-Chip Market, Segmentation By Organ Type, 2017, (% share)

Figure 15: Global Organ-On-Chip Market Segmentation By End-Users, 2017, Value (USD million)

Figure 16: North America Organ-On-Chip Market, Historic Market Size, 2013-2017, Value (USD million)

Figure 17: North America Organ-On-Chip Market, Forecast Market Size, 2017-2021, Value (USD million)

Figure 18: Europe Organ-On-Chip Market, Historic Market Size, 2013-2017, Value (USD million)

Figure 19: Europe Organ-On-Chip Market, Forecast Market Size, 2017-2021, Value (USD million)

Figure 20: Asia Organ-On-Chip Market, Historic Market Size, 2013-2017, Value (USD million)

Figure 21: Asia Organ-On-Chip Market, Forecast Market Size, 2017-2021, Value (USD million)

Figure 22: ROW Organ-On-Chip Market, Historic Market Size, 2013-2017, Value (USD million)

Figure 23: ROW Organ-On-Chip Market, Forecast Market Size, 2017-2021, Value (USD million)

Figure 24: Global Organ-On-Chip Market, Predictability Scale Of Techniques In Drug Screening And Evaluation

Figure 25: Global Organ-On-Chip Market, Number Of New Drug Approvals By FDA And EMA, 2013-2016

Figure 26: Global Organ-On-Chip Market Funding Landscape Split By Regions, 2015-2017, Value, (USD million)

Figure 27: Global Organ-On-Chip Market Key Competitors Revenues, 2017 (USD million)


List Of Table

Table 1: Global Organ-On-Chip Market, List Of Universities And Their Spin-offs

Table 2: Global Organ-On-Chip Market, Historic Market Size, 2013-2017, Value (USD million)

Table 3: Global Organ-On-Chip Market, Forecast Market Size, 2017-2021, Value (USD million)

Table 4: Global Organ-On-Chip Market,Segmentation By Organ Type, 2017, (% share)

Table 5: Global Organ-On-Chip Market, Segmentation By End-Users, 2017, Value (USD million)

Table 6: North America Organ-On-Chip Market, Historic Market Size, 2013-2017, Value (USD million)

Table 7: North America Organ-On-Chip Market, Forecast Market Size, 2017-2021, Value (USD million)

Table 8: Europe Organ-On-Chip Market, Historic Market Size, 2013-2017, Value (USD million)

Table 9: Europe Organ-On-Chip Market, Forecast Market Size, 2017-2021, Value (USD million)

Table 10: Asia Organ-On-Chip Market, Historic Market Size, 2013-2017, Value (USD million)

Table 11: Asia Organ-On-Chip Market, Forecast Market Size, 2017-2021, Value (USD million)

Table 12: ROW Organ-On-Chip Market, Historic Market Size, 2013-2017, Value (USD million)

Table 13: ROW Organ-On-Chip Market, Forecast Market Size, 2017-2021, Value (USD million)

Table 14: Global Organ-On-Chip Market, Top Pharmaceutical Companies-R&D Expenditures, 2015 and 2016, (USD billion)

Table 15: Global Organ-On-Chip Market, Number Of New Drug Approvals By FDA And EMA, 2013-2016

Table 16: Global Organ-On-Chip Market, Institutions Funded By NIH, 2017

Table 17: Global Organ-On-Chip Market, Institutions Funded By NCATS For Tissue Chip Testing Centers, 2016

Table 18: Global Organ-On-Chip Market, Institutions Funded By NCATS, 2017

Table 19: Global Organ-On-Chip Market, CN Bio Collaborations With Pharmaceutical Companies

Table 20: Global Organ-On-Chip Market, CN Bio Collaborations With Academic Institutions

Table 21: Global Organ-On-Chip Market, H�REL Products and its Description

Table 22: Global Organ-On-Chip Market, InSphero Products and its Description

Table 23: Global Organ-On-Chip Market, InSphero Collaborations With Academic Universities And Industries

  • Single User License (for access by one person)
  • Site License (for access of one office location of a company)
  • Corporate License (allow access by all staff of the company)
To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Lung-on-chip, Heart-on-chip, Liver-on-chip, Intestine-on-chip, Kidney-on-chip and Human-on-chip


Companies

North America: Emulate Inc., H�REL Corporation (H�REL), Nortis, Tara Biosystems, AxoSim Techologies LLC, Organovo, ASCENDANCE BIOTECHNOLOGY - HEPREGEN,

Europe: CN Bio Innovations, TissUse GmbH, Mimetas, InSphero, HemoShear, Roche Holding AG, Elvesys, Cherry Biotech, 4Dcell

Asia: Kyoto University